NYSE:WSTLife Sciences
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio
West Pharmaceutical Services (NYSE:WST) has agreed to sell all manufacturing and supply rights for its SmartDose 3.5mL On Body Delivery System to AbbVie.
The deal covers only the 3.5mL version; West will continue to supply other SmartDose configurations.
The agreement represents a notable shift in West's product portfolio and its role in large volume drug delivery partnerships.
For you as an investor, this move sits at the core of what West does as a provider of drug delivery and packaging...